CRP and glycogen storage disease VI: There weren’t significant differences in age, gender, age at diagnosis, diagnostic delay, active joint count at diagnosis, patient/parent VAS pain scores at diagnosis, physician VAS pain score at diagnosis, acute-phase reactant levels (ESR and CRP) at diagnosis, or RF titer and anti-CCP levels between the patients with inactive disease and active disease at 24 months.